Advertisement
EXR vs NHPAP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXR is a Buy and NHPAP is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXR’s FA Score shows that 1 FA rating(s) are green whileNHPAP’s FA Score has 1 green FA rating(s).
- EXR’s FA Score: 1 green, 4 red.
- NHPAP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXR’s TA Score shows that 4 TA indicator(s) are bullish while NHPAP’s TA Score has 3 bullish TA indicator(s).
- EXR’s TA Score: 4 bullish, 5 bearish.
- NHPAP’s TA Score: 3 bullish, 5 bearish.
Price Growth
EXR (@Miscellaneous Manufacturing) experienced а -3.49% price change this week, while NHPAP (@Managed Health Care) price change was +1.48% for the same time period.
The average weekly price growth across all stocks in the @Miscellaneous Manufacturing industry was -0.10%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +7.37%.
The average weekly price growth across all stocks in the @Managed Health Care industry was -0.16%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +11.57%.
Reported Earning Dates
EXR is expected to report earnings on Nov 04, 2025.
NHPAP is expected to report earnings on Dec 03, 2025.
Industries' Descriptions
@Miscellaneous Manufacturing (-0.10% weekly)Miscellaneous manufacturing refers to a diverse range of products that cannot readily be categorized into other specific sectors of manufacturing. Major U.S. players in this industry include AMETEK, Inc.( analytical instruments, precision components and specialty materials), Dover Corporation (solutions for efficiency and safety of extracting oil and gas, e.g. rod lifts, progressing cavity pumps, gas lifts etc.; solutions for the transportation/transformation of solid waste; products for safe handling of critical fluids for various industries; systems for commercial-refrigeration, heating and cooling, and food and beverage packaging), and Carlisle Companies Incorporated (niche markets including commercial roofing, energy, lawn and garden, mining and construction equipment, aerospace and electronics, dining and food delivery, and healthcare), among others.
@Managed Health Care (-0.16% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| EXR | NHPAP | EXR / NHPAP | |
| Capitalization | 29.2B | N/A | - |
| EBITDA | 2.43B | 69.3M | 3,506% |
| Gain YTD | -4.837 | 37.989 | -13% |
| P/E Ratio | 29.94 | N/A | - |
| Revenue | 3.31B | 348M | 951% |
| Total Cash | 32M | 47.1M | 68% |
| Total Debt | 13.6B | 1.04B | 1,305% |
EXR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 65 | |
SMR RATING 1..100 | 79 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EXR | NHPAP | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 29% |
| Stochastic ODDS (%) | 2 days ago 55% | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 58% | 2 days ago 42% |
| MACD ODDS (%) | 2 days ago 50% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 44% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 39% |
| Advances ODDS (%) | 16 days ago 65% | 5 days ago 45% |
| Declines ODDS (%) | 3 days ago 61% | 3 days ago 46% |
| BollingerBands ODDS (%) | 2 days ago 52% | 2 days ago 38% |
| Aroon ODDS (%) | 2 days ago 60% | 3 days ago 35% |
Advertisement
EXR and
Correlation & Price change
A.I.dvisor indicates that over the last year, EXR has been closely correlated with NSA. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if EXR jumps, then NSA could also see price increases.
NHPAP and
Correlation & Price change
A.I.dvisor indicates that over the last year, NHPAP has been loosely correlated with EXR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NHPAP jumps, then EXR could also see price increases.
| Ticker / NAME | Correlation To NHPAP | 1D Price Change % | ||
|---|---|---|---|---|
| NHPAP | 100% | +0.38% | ||
| EXR - NHPAP | 33% Loosely correlated | +0.04% | ||
| CUBE - NHPAP | 31% Poorly correlated | -0.10% | ||
| PCH - NHPAP | 31% Poorly correlated | -1.63% | ||
| STAG - NHPAP | 31% Poorly correlated | -0.35% | ||
| PSA - NHPAP | 30% Poorly correlated | -0.16% | ||
More | ||||